SCHEMBL19638099

SCHEMBL19638099

N#Cc1cccc(-c2nc(NC(=O)c3ccc(C(=O)O)s3)sc2C#N)c1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADORA2A P29274 4/20 0.53
ADORA3 P0DMS8 4/20 0.49
ADORA1 P30542 3/20 0.49
HPGDS O60760 1/20 0.45
ESRRG P62508 1/20 0.44
RORC P51449 2/20 0.42
PTGDR2 Q9Y5Y4 1/20 0.41
F11 P03951 1/20 0.39
PIN1 Q13526 1/20 0.39
PRKDC P78527 1/20 0.39
ATR Q13535 1/20 0.39
PDE4A P27815 1/20 0.39
PDE4C Q08493 1/20 0.39
PDE4D Q08499 1/20 0.39
MEN1 O00255 1/20 0.39
LMNA P02545 1/20 0.39
PKM P14618 1/20 0.39
RAB9A P51151 1/20 0.39
KMT2A Q03164 1/20 0.39
NPSR1 Q6W5P4 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19637993 0.89 ADORA2A (0.65) ADORA2AADORA3ADORA1MEN1LMNA
SCHEMBL19638106 0.88 ADORA3 (0.56) ADORA2AADORA3ADORA1ESRRGMEN1
SCHEMBL19638250 0.87 ADORA2A (0.54) ADORA2AADORA3ESRRGPTGDR2MEN1
SCHEMBL19638387 0.86 ADORA3 (0.57) ADORA2AADORA3ADORA1MEN1LMNA
SCHEMBL19638026 0.83 ADORA2A (0.53) ADORA2AADORA3ADORA1MEN1LMNA
SCHEMBL19638113 0.82 ADORA2A (0.54) ADORA2AADORA3ADORA1ESRRGPTGDR2
SCHEMBL19638040 0.81 ADORA2A (0.60) ADORA2AADORA3ADORA1RORCMEN1
SCHEMBL19638317 0.80 ADORA3 (0.55) ADORA2AADORA3MEN1LMNARAB9A
SCHEMBL19638109 0.79 ADORA3 (0.53) ADORA2AADORA3MEN1LMNAPKM
SCHEMBL19638094 0.79 ADORA3 (0.55) ADORA2AADORA3ADORA1MEN1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3248964-B1 THIAZOLE MODULATORS OF A3 ADENOSINE RECEPTORS PALOBIOFARMA SL (ES) 2019-07-17 EP claimed
US-10238637-B2 Modulators of the adenosine A3 receptors PALOBIOFARMA, S.L. (ES) 2019-03-26 US claimed
US-20180263963-A1 MODULATORS OF THE ADENOSINE A3 RECEPTORS PALOBIOFARMA, S.L. (ES) 2018-09-20 US claimed
EP-3248964-A1 THIAZOLE MODULATORS OF A3 ADENOSINE RECEPTORS PALOBIOFARMA S.L. (ES) 2017-11-29 EP claimed
CN-107207445-B Adenosine A3Modulators of receptors 帕罗生物制药有限公司 2021-03-16 CN disclosed
EP-3248964-B1 THIAZOLE MODULATORS OF A3 ADENOSINE RECEPTORS PALOBIOFARMA SL (ES) 2019-07-17 EP disclosed
US-10238637-B2 Modulators of the adenosine A3 receptors PALOBIOFARMA, S.L. (ES) 2019-03-26 US disclosed
US-20180263963-A1 MODULATORS OF THE ADENOSINE A3 RECEPTORS PALOBIOFARMA, S.L. (ES) 2018-09-20 US disclosed
EP-3248964-A1 THIAZOLE MODULATORS OF A3 ADENOSINE RECEPTORS PALOBIOFARMA S.L. (ES) 2017-11-29 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180263963-A1 MODULATORS OF THE ADENOSINE A3 RECEPTORS ADORA3, ADORA2A, ADORA1 ADORA2A 2/4885ADORA3 1/4885ADORA1 3/4885
US-10238637-B2 Modulators of the adenosine A3 receptors ADORA3, ADORA2A, ADORA1 ADORA2A 2/4885ADORA3 1/4885ADORA1 3/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.